Skip to main content
Premium Trial:

Request an Annual Quote

NIH Commercialization Assistance Program Aimed at SBIR Awardees

NEW YORK (GenomeWeb News) – The National Institutes of Health said today it has renewed a program aimed to help small life sciences businesses that have been recent or current Small Business Innovation Research Phase II awardees move their products or services toward the market.
The Commercialization Assistance Program, now in its fifth year, will last until June 2009.
The CAP program is designed to help small and promising life science companies develop commercial businesses and develop their products for the market. Through a contract with the Larta Institute of Los Angeles, the CAP will provide participants with individualized assistance in reaching their goals.
The ten-month program will offer two tracks: the Commercialization Training Track, or CTT, and the Accelerator Commercialization Track, or ACT.
The CTT is aimed at providing training and mentoring from industry and investment professionals, and the ACT is geared toward helping participants achieve clear and specific near-term objectives and plans, using experts with current market experience.
All NIH SBIR awardees that have a Phase II award that is active or that was active in the past five years are eligible for the program.
The deadline for applications for the program is Sept. 26. More information is available here.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.